NRD
ISRG icon

Nebula Research & Development’s Intuitive Surgical ISRG Stock Holding History

Nebula Research & Development’s Portfolio ISRG Stock Details ISRG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,517
Closed -$3M – 434
2025
Q2 		$3M Buy
5,517
+5,018
+1,006% +$2.62M 0.26% 92
2025
Q1 		$247K Sell
499
-1,050
-68% -$581K 0.02% 811
2024
Q4 		$809K Buy
+1,549
New +$807K 0.09% 366
2024
Q2 		– Sell
-2,636
Closed -$1.05M – 919
2024
Q1 		$1.05M Buy
2,636
+1,878
+248% +$710K 0.23% 128
2023
Q4 		$256K Buy
+758
New +$226K 0.08% 480

Other funds holding ISRG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Nebula Research & Development's ISRG Position: Q3 2025 in Review

Nebula Research & Development sold out of Intuitive Surgical (ISRG) in Q3 2025, closing a stake of 5,517 shares — an estimated $3M sold.

Nebula Research & Development first reported a position in ISRG in Q4 2023 and held it in 5 quarters. The position peaked at $3M in Q2 2025. 2,110 funds tracked by Wall St. Rank hold ISRG as of Q3 2025.

  • Nebula Research & Development reported no remaining Intuitive Surgical position as of Q3 2025 after selling out during the quarter.
  • Nebula Research & Development sold 5,517 Intuitive Surgical shares in Q3 2025, an estimated $3M.
  • Nebula Research & Development first reported a position in Intuitive Surgical in Q4 2023 and held it in 5 quarters.
  • Nebula Research & Development's Intuitive Surgical position peaked at $3M in Q2 2025.
  • 2,110 funds tracked by Wall St. Rank held Intuitive Surgical as of Q3 2025.

Based on Nebula Research & Development's 13F filing for Q3 2025.